| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 126.56B | 139.22B | 121.46B | 117.32B | 114.97B | 109.50B |
| Gross Profit | 25.92B | 30.33B | 25.10B | 23.22B | 23.92B | 23.95B |
| EBITDA | 16.61B | 20.31B | 15.91B | 14.14B | 15.23B | 15.38B |
| Net Income | 10.36B | 12.49B | 9.92B | 8.18B | 9.49B | 8.93B |
Balance Sheet | ||||||
| Total Assets | 115.03B | 125.93B | 122.21B | 124.45B | 122.92B | 115.89B |
| Cash, Cash Equivalents and Short-Term Investments | 25.31B | 29.98B | 30.95B | 34.93B | 30.61B | 32.02B |
| Total Debt | 1.69B | 1.83B | 1.66B | 1.55B | 1.83B | 882.00M |
| Total Liabilities | 29.75B | 35.04B | 33.53B | 33.35B | 37.48B | 35.06B |
| Stockholders Equity | 84.47B | 90.01B | 87.83B | 90.19B | 84.50B | 80.74B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.45B | 5.63B | 10.59B | 1.81B | 5.63B |
| Operating Cash Flow | 0.00 | 13.66B | 10.35B | 14.59B | 4.76B | 8.60B |
| Investing Cash Flow | 0.00 | -1.89B | -1.90B | -4.25B | 487.00M | -2.35B |
| Financing Cash Flow | 0.00 | -12.95B | -12.40B | -5.33B | -5.76B | -4.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥146.84B | 13.90 | ― | 3.22% | 14.62% | 33.65% | |
79 Outperform | ¥128.92B | 11.03 | ― | 1.55% | 17.21% | 65.71% | |
64 Neutral | ¥165.24B | 15.99 | ― | 2.87% | -1.92% | -12.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥122.69B | 9.39 | ― | 2.89% | 16.39% | 101.50% | |
62 Neutral | ¥148.55B | 11.44 | ― | 3.44% | 1.86% | 11.05% | |
59 Neutral | ¥100.84B | 11.00 | ― | 3.13% | 10.13% | 13.31% |